AS
andrew spencer
The Australian Centre for Blood Diseases, Monash University, Melbourne
Australia
Authors
- CC
chong chen
Blood Disease Institute, Key Laboratory of Bone Marrow Stem Cell, Xuzhou Medical University
China
- EA
enrica antonia martino
Hematology Unit, Department of Onco-Hematology, Azienda Ospedaliera (AO) of Cosenza
Italy
- EV
ernesto vigna
Hematology Unit, Department of Onco-Hematology, Azienda Ospedaliera (AO) of Cosenza
Italy
- FM
fortunato morabito
Associazione Italiana contro le Leucemie - Linfomi e Mieloma (AIL) Sezione di Cosenza
Italy
- FM
francesco mendicino
Hematology Unit, Department of Onco-Hematology, Azienda Ospedaliera (AO) of Cosenza
Italy
- HP
holly pertile
Department of Haematology, St Vincent’s Hospital Melbourne, Fitzroy
Australia
- HZ
huan-xin zhang
Blood Disease Institute, Key Laboratory of Bone Marrow Stem Cell, Xuzhou Medical University
China
- JC
jiang cao
Blood Disease Institute, Key Laboratory of Bone Marrow Stem Cell, Xuzhou Medical University
China
- KJ
kenneth jc lim
The Australian Centre for Blood Diseases, Monash University, Melbourne
Australia
- MG
massimo gentile
Hematology Unit, Department of Onco-Hematology, Azienda Ospedaliera (AO) of Cosenza
Italy
- NA
nicola amodio
Department of Experimental and Clinical Medicine, University of Catanzaro
Italy
